Skip to main content

Headlines

Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock.
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Stock Market Midday, Sept. 30: Markets Rise on Softer Inflation Data, Investors Await Micron Earnings
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Avacta H1 Loss Widens As AVA6103 Advances Toward 2027 Data
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Ernexa Reports Positive ERNA-101 Safety Data Ahead Of Q4 IND
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Futures Move To The Upside Following Tamer-Than-Expected Inflation Data
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Not Chips. Not Memory. Data Center Cooling Is the Unsung AI Infrastructure Play Nobody's Watching
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Jade Bioscience Reports Preclinical Data For JADE301
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Connect Biopharma Reports Positive Phase 2 Rademikibart Data In Acute COPD
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Rafael Reports Phase 3 Trappsol Cyclo Data In NPC
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Higher Crude Oil Prices, Weak Economic Data Weigh On French Stocks
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Argenx To Present New VYVGART Data Across Autoimmune Neuromuscular Disorder At AANEM & MGF Session
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Zealand Publishes New Phase 2 Data For Petrelintide Showing Improved Cardiometabolic Benefits
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Galderma Reports Three-Year Nemluvio Data In Moderate-to-Severe Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Dyne Reports One-Year Z-Basivarsen Data Showing Functional Improvements In DM1
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
U.S. Stocks Lack Direction Ahead Of Key Inflation Data
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks